4.5 Interaction with other medicinal products and other forms of interaction  
 Live vaccines should not be given concurrently with secukinumab  (see also section  4.4). 
 In a study in adult subjects with plaque psoriasis, no interaction was observed between secukinumab and midazolam (CYP3A4 substrate).  
 No interaction was seen when secukinumab  was administered concomitantly with methotrexate (MTX) and/or corticosteroids in arthritis studies (including in patients with psoriatic arthritis and axial spondyloarthritis ). 
 
